BIO 140 - Onc BioAlternative Names: BIO140 - Onc Bio
Latest Information Update: 11 Jan 2008
At a glance
- Originator Onc Bio
- Class Monoclonal antibodies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Brain cancer
Most Recent Events
- 06 Oct 2005 Phase-I clinical trials in Brain cancer in USA (Intrathecal)